Clinical study on treatment of refractory wounds with platelet-rich plasma

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2400079417

Enrollment

Unknown

Registered

2024-01-03

Start date

2024-01-15

Completion date

Unknown

Last updated

2024-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

refractory wounds

Interventions

1:Conventional treatment methods, such as dressing change, debridement and antibiotics, were used

2:Platelet-rich plasma therapy was performed with routine dressing changes, debridement, antibiotics and platelet-rich plasma

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Patients aged 18-65 years with a refractory wound area between 2 and 10cm² who have not received other biologic therapies.

Exclusion criteria

Exclusion criteria: Patients suffering from serious diseases of the heart, liver, kidney and other organs; Patients allergic to platelet-rich plasma; Pregnant or lactating female patients; Patients who cannot receive long-term follow-up observation.

Design outcomes

Primary

Measure	Time frame
Wound healing time;Wound healing rate;	—

Countries

China

Contacts

Public ContactDong wang

The Seventh Affiliated Hospital, Sun Yat-sen University

Wangdong@sysush.com+86 136 8885 6996

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026